LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 23 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675,106 | +89.2% | 121,422 | +149.8% | 0.00% | – |
| Q2 2023 | $356,805 | +141.4% | 48,611 | +29.2% | 0.00% | – |
| Q1 2023 | $147,811 | +24.4% | 37,611 | 0.0% | 0.00% | – |
| Q4 2022 | $118,851 | -12.0% | 37,611 | 0.0% | 0.00% | – |
| Q3 2022 | $135,000 | +16.4% | 37,611 | 0.0% | 0.00% | – |
| Q2 2022 | $116,000 | -40.5% | 37,611 | -0.0% | 0.00% | – |
| Q1 2022 | $195,000 | -20.7% | 37,624 | -26.0% | 0.00% | – |
| Q4 2021 | $246,000 | -51.8% | 50,850 | -11.2% | 0.00% | -100.0% |
| Q3 2021 | $510,000 | +233.3% | 57,275 | +237.1% | 0.00% | – |
| Q2 2021 | $153,000 | -44.8% | 16,993 | 0.0% | 0.00% | – |
| Q1 2021 | $277,000 | – | 16,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |